CC™ VideoSpective
CREDITS: HISTORYVILLE
The consummate global news and information portal
CC™ PersPective
By Staff
A Nigerian researcher based in the United States, Cynthia Osuala, is spearheading groundbreaking research in graphene-based quantum technologies that could transform national security, advanced communications, and next-generation computing.
Osuala, a physicist and research scientist, is investigating how the unique quantum properties of graphene — one-atom-thick material celebrated as the “wonder material” of the 21st century can be harnessed to build quantum sensors and computing components with unprecedented precision and efficiency.
Her work revolves around solving one of the most pressing challenges in modern physics and engineering: how to model devices capable of detecting extremely weak signals and processing massive amounts of data at speeds far beyond the limits of traditional electronics.
In one of her notable projects, Osuala developed advanced models to simulate quantum transport in graphene devices, revealing how electron pathways can be tuned to minimize noise and improve sensitivity. This modeling work provides a blueprint for constructing highly quantum sensors capable of detecting even the faintest changes in magnetic or electric fields — an ability critical for applications in defense, environmental monitoring, and secure communication systems.
“Graphene’s extraordinary mobility and low resistivity make it ideal for pushing the boundaries of sensing and computing technologies,” Osuala explained. “By leveraging these properties, we can design devices that are smaller, faster, and more sensitive than anything currently available.”
Her research builds on a series of significant milestones, including the first demonstration of the Aharonov-Bohm effect in chemical vapor deposition (CVD)-grown graphene rings at cryogenic temperatures. This breakthrough revealed how quantum interference effects in graphene can be harnessed for real-world applications, laying the foundation for highly sensitive quantum technologies. The work earned her the Best Paper Award at the IEEE Conference on Nanoelectronics and Nanotechnology. She has also been featured in a Stevens Institute of Technology Research & Innovation article titled “Traveling Light,” where she discussed the broader implications of her research in making quantum technologies more practical and scalable.
Beyond the lab, Osuala is a strong advocate for STEM education and diversity in science. She has served as a mentor and judge in science competitions, inspiring young scientists and helping address the underrepresentation of women and minorities in physics.
“This research is more than an academic pursuit,” Osuala emphasized. “It’s about building the technologies that will define the future technologies that ensure resilience, security, and innovation.”
Her contributions exemplify international leadership that advances materials science and quantum technology while strengthening U.S. innovation in emerging quantum systems.
![]() |
| Dr. Akabogu-Collins |
CC™ VideoSpective
![]() |
| Ex-Chelsea and Monaco Sporting Director Mike Emenalo |
CC™ Opinion
By Dr. James Dobson
Defying common sense, biological reality, and the beliefs of most Americans, senior leaders at companies including Mars, Inc., and Nestle USA, have gone all in on the LGBTQ agenda.
These companies are pledging to "us[e] our influence to advocate for policies that establish full equality at the federal and state levels, including swift Senate passage of the Equality Act."
What this really means is that these companies support gender mutilation of children through "gender reassignment" surgeries, believe that the religious freedom guaranteed by the First Amendment is inconsistent with a "progressive" America, and believe that Americans who think differently are bigots who should be silenced and expelled from society.
The question is, will conservatives and people of faith fight back? They should! Here is what Tony Perkins, president of the Family Research Council, said about this corporate posturing:
“With that much activism, who has time to sell candy? And in this heated climate, who will buy it? Considering the backlash against Coke, Delta, Major League Baseball, and Patagonia, this is an incredibly tone-deaf move for the makers of Twix, Starburst, and M&Ms. The American people have made it quite clear that they're fed up with corporations picking sides in politics. Just this week, three-quarters of the country said companies should stay out of politics, and a solid majority (64 percent) said they'd consider walking away from the ones who didn't. Obviously, that message didn't make it to Kit-Kat headquarters."
Maybe it's time that message did make it to headquarters. Stand with us—and for America—by contacting Mars, Inc. and Nestle, USA and let them know what you think about corporate activism.

Scientists examining documents dating back 3,500 years say they have found proof that the origins of modern medicine lie in ancient Egypt and not with Hippocrates and the Greeks.
The research team from the KNH Centre for Biomedical Egyptology at The University of Manchester discovered the evidence in medical papyri written in 1,500BC - 1,000 years before Hippocrates was born.
"Classical scholars have always considered the ancient Greeks, particularly Hippocrates, as being the fathers of medicine but our findings suggest that the ancient Egyptians were practising a credible form of pharmacy and medicine much earlier," said Dr Jackie Campbell.
"When we compared the ancient remedies against modern pharmaceutical protocols and standards, we found the prescriptions in the ancient documents not only compared with pharmaceutical preparations of today but that many of the remedies had therapeutic merit."
The medical documents, which were first discovered in the mid-19th century, showed that ancient Egyptian physicians treated wounds with honey, resins and metals known to be antimicrobial.
The team also discovered prescriptions for laxatives of castor oil and colocynth and bulk laxatives of figs and bran. Other references show that colic was treated with hyoscyamus, which is still used today, and that cumin and coriander were used as intestinal carminatives.
Further evidence showed that musculo-skeletal disorders were treated with rubefacients to stimulate blood flow and poultices to warm and soothe. They used celery and saffron for rheumatism, which are currently topics of pharmaceutical research, and pomegranate was used to eradicate tapeworms, a remedy that remained in clinical use until 50 years ago.
"Many of the ancient remedies we discovered survived into the 20th century and, indeed, some remain in use today, albeit that the active component is now produced synthetically," said Dr Campbell.
"Other ingredients endure and acacia is still used in cough remedies while aloes forms a basis to soothe and heal skin conditions."
Fellow researcher Dr Ryan Metcalfe is now developing genetic techniques to investigate the medicinal plants of ancient Egypt. He has designed his research to determine which modern species the ancient botanical samples are most related to.
"This may allow us to determine a likely point of origin for the plant while providing additional evidence for the trade routes, purposeful cultivation, trade centres or places of treatment," said Dr Metcalfe.
"The work is inextricably linked to state-of-the-art chemical analyses used by my colleague Judith Seath, who specialises in the essential oils and resins used by the ancient Egyptians."
Professor Rosalie David, Director of the KNH Centre, said: "These results are very significant and show that the ancient Egyptians were practising a credible form of pharmacy long before the Greeks.
"Our research is continuing on a genetic, chemical and comparative basis to compare the medicinal plants of ancient Egypt with modern species and to investigate similarities between the traditional remedies of North Africa with the remedies used by their ancestors of 1,500 BC."
The research is being funded by the Leverhulme Trust.
CC™ VideoSpective